Abstract:ABSTRACT Downregulation of protein kinase C δ (PKC δ) by treatment with the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) transforms cells that overexpress the non-receptor class tyrosine kinase c-Src (Z. Lu et al., Mol. Cell. Biol. 17:3418–3428, 1997). We extended these studies to cells overexpressing a receptor class tyrosine kinase, the epidermal growth factor (EGF) receptor (EGFR cells); like c-Src, the EGF receptor is overexpressed in several human tumors. In contrast with expectations, downregulation of PKC isoforms with TPA did not transform the EGFR cells; however, treatment with EGF did transform these cells. Since TPA downregulates all phorbol ester-responsive PKC isoforms, we examined the effects of PKC δ- and PKC α-specific inhibitors and the expression of dominant negative mutants for both PKC δ and α. Consistent with a tumor-suppressing function for PKC δ, the PKC δ-specific inhibitor rottlerin and a dominant negative PKC δ mutant transformed the EGFR cells in the absence of EGF. In contrast, the PKC α-specific inhibitor Go6976 and expression of a dominant negative PKC α mutant blocked the transformed phenotype induced by both EGF and PKC δ inhibition. Interestingly, both rottlerin and EGF induced substantial increases in phospholipase D (PLD) activity, which is commonly elevated in response to mitogenic stimuli. The elevation of PLD activity in response to inhibiting PKC δ, like transformation, was dependent upon PKC α and restricted to the EGFR cells. These data demonstrate that PKC isoforms α and δ have antagonistic effects on both transformation and PLD activity and further support a tumor suppressor role for PKC δ that may be mediated by suppression of tyrosine kinase-dependent increases in PLD activity.

Regulation of Phosphatidic Acid Phosphohydrolase by Epidermal Growth Factor

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

Regulation of TGF-beta signalling by protein phosphatases.

Phosphatidic acid-PKA signaling regulates p38 and ERK1/2 functions in ligand-independent EGFR endocytosis

Phosphatidylinositol (4,5)-bisphosphate drives the formation of EGFR and EphA2 complexes

Carboxy-Terminal Truncations Of Epidermal Growth-Factor (Egf) Receptor Affect Diverse Egf-Induced Cellular-Responses

Phospholipase D and RalA Cooperate with the Epidermal Growth Factor Receptor to Transform 3Y1 Rat Fibroblasts.

Bilateral regulation of EGFR activity and local PI(4,5)P 2 dynamics in mammalian cells observed with superresolution microscopy

Platelet-derived Growth Factor Requires Epidermal Growth Factor Receptor to Activate p21-activated Kinase Family Kinases

Signaling functions of phosphatidic acid.

Regulation of the Function of P-glycoprotein by Epidermal Growth Factor Through Phospholipase C

Bilateral regulation of EGFR activity and local PI dynamics observed with superresolution microscopy

Direct Activation of TACE-Mediated Ectodomain Shedding by P38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation

Activation of membrane protein-tyrosine phosphatase involving cAMP- and Ca2+/phospholipid-dependent protein kinases

Antagonistic Effects of Protein Kinase C Α and Δ on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor

Phospho-substrate profiling of Epac-dependent protein kinase C activity

Phosphoprotein Phosphatase 1 is Required for Extracellular Calcium-Induced Keratinocyte Differentiation

The role of peroxisome proliferator-activated receptor-β/δ in epidermal growth factor-induced HaCaT cell proliferation

Critical role for the catalytic activity of phospholipase C-γ1 in epidermal growth factor-induced cell migration

Phosphoproteomic investigation of targets of protein phosphatases in EGFR signaling

A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling